Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Could Launch Three Significant NMEs in 2004; Will Any Surpass Viagra?

Dec 29 2003

• By The Pink Sheet

Related Content

CBER’s Long Goodbye: Biologics Approval Time Jumps To 30 Months In 2002

Dec 30 2002

New Drug Approvals In 2003 Could Include Four HIV Agents

Dec 30 2002

Pfizer/Pharmacia Sales Force Debuts In June; Inspra Launch Delayed

Apr 28 2003

Quarterly Call Round-Up: Pfizer, GSK, Lilly Updates

Nov 03 2003

Neurontin Ruling Is Guide For DoJ Off-Label Promotion Cases – Prosecutor

Oct 13 2003

Inspra Approved For First-Line CHF; Pfizer Expects Most Use Will Be Add-On

Oct 13 2003

Alpharma Generic Neurontin Approval Precedes FDA Reinspection

Sep 22 2003

Wyeth-Ayerst Acel-Imune Discontinued; DTaP Vaccine Had Sales Of $71 Mil.

Jan 29 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window